About
Basic Data Updated:
4 months agoIncorporated in 2015, Eyestem Research Private Limited is a pioneering cell therapy company that offers a range of cutting-edge services in the field of ophthalmology. With a strong focus on innovation and research, the company has established itself as a leader in the industry. One of the key services offered by Eyestem is clinical trials, which play a crucial role in the development of new treatments and therapies. Through these trials, the company is able to gather valuable data and insights, which are then used to improve and refine their offerings. In addition to clinical trials, Eyestem also specializes in cell therapy, a revolutionary approach to treating various medical conditions. Through their state-of-the-art platform, EyecyteRPE, the company is able to effectively treat Dr... Read More
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Website1222442
- Telephone1222442
- Email Address1222442
- Social Media1222442
| CIN/LLPIN/FCRN | U74999KA2015PTC164505 |
| Company No. | 084306 |
| Company Classification | Private Limited Indian Non-Government Company |
| Incorporation Date | 25 Aug 2015 |
| Date of AGM | 30 Sep 2023 |
| Date of Balance Sheet | 31 Mar 2023 |
| Listing Status | Unlisted |
| ROC Code | Roc Bangalore |
Financials of Eyestem Research Private Limited
Enhance accessibility to Eyestem Research's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Corporate Structure
Unlock access to Eyestem Research's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Eyestem Research Private Limited
Unlock and access historical data on people associated with Eyestem Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Board Members(8)
Charges (Loans)
There are no open charges registered against the company as per our records.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eyestem Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eyestem Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
Nkure Therapeutics Private Limited
Active
2 years 2 months Mahendra Rao and Ashok Vohra are mutual person
Centre For Cellular And Mollecular Platforms
Active 14 years 4 months Subramanian Ramaswamy is a mutual person
Escape Velocity Accelerator India Private Limited
Active 10 years 3 months Ashok Vohra is a mutual person
Recent activity within the organization
Annual General Meeting
Eyestem Research Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
30 Sep 2023Balance Sheet
Eyestem Research Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Bangalore.
31 Mar 2023Director Appointment
Gerardus Adrianus Hoogland was appointed as a Director was appointed as a Director on 07 Sep 2020 & has been associated with this company since 3 years 8 months .
07 Sep 2020Director Appointment
Subramanian Ramaswamy was appointed as a Director was appointed as a Director on 13 Jan 2020 & has been associated with this company since 4 years 3 months .
13 Jan 2020Director Appointment
Suresh Ramu was appointed as a Director was appointed as a Director on 07 Nov 2017 & has been associated with this company since 6 years 6 months .
07 Nov 2017
Recent News, Updates & Announcement
Biotech Firm Eyestem Partners with RetinAI to Innovate Geographic Atrophy Clinical Research Using StateoftheArt AI Technology.Eyestem Research a Bangalorebased biotechnology company specialising in cell therapy approaches has entered a strategic partnership with .
Blogger 31 Oct 2023
- Eyestem files for IND approval for its product to treat geographic atrophy.
Eyestem Research has announced the submission of IND application to CDSCO to start first inhuman trials of EyecyteRPEfor subjects.
Economic Times 05 Jun 2023
- Eyestem Files for IND Approval for Its Product to Treat Geographic Atrophy the Largest Cause of Incurable Blindness in the World for People Over 50.
Dry agerelated macular degeneration dry AMD is the largest cause of incurable blindness in the world for patients over 50 years 170 mill.
Blogger 05 Jun 2023
- Eyestem files for CDSCO approval for EyecyteRPE.
EyecyteRPE will be used to treat geographic atrophy Eyestem Research announced the submission of an Investigational New Drug IND application to the Central Drugs Standards Control Organization Ind.
IndiaMedToday 05 Jun 2023
- Bengalurubased Eyestem announces US operations appoints Ravi Achar as Head North America Strategy.
Engages Stradling Yocca Carlson amp Rauth as its US law firm Eyestem a Bengalurubased Cell Therapy company with a focus on ophthalmology has appointed Ravi Achar as Head North America Strategy.
IndiaMedToday 23 Feb 2023
Frequently asked questions
What is the Incorporation or founding date of Eyestem Research Private Limited?
